Stockreport

Shares of Conatus Pharmaceuticals plummet over 50% after Phase 2 trial fails to meet primary endpoint [MarketWatch]

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations
PDF Shares of Conatus Pharmaceuticals plummet over 50% after Phase 2 trial fails to meet primary endpoint Shares of Conatus Pharmaceuticals Inc. CNAT, -57.55% plummeted 5 [Read more]